NCI advocates use of adjuvant therapy for rectal cancer. | Am Fam Physician;43(4): 1440-2, 1444, 1991 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

NCI advocates use of adjuvant therapy for rectal cancer.

Am Fam Physician ; 43(4): 1440-2, 1444, 1991 Apr.

Article in En | MEDLINE | ID: mdl-2008825

Subject(s)

Fluorouracil/administration & dosage; Rectal Neoplasms/therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Combined Modality Therapy; Humans; National Institutes of Health (U.S.); Rectal Neoplasms/drug therapy; Rectal Neoplasms/radiotherapy; Semustine/administration & dosage; Semustine/adverse effects; United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Fluorouracil Type of study: Clinical_trials Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am Fam Physician Year: 1991 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Fluorouracil Type of study: Clinical_trials Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am Fam Physician Year: 1991 Document type: Article Country of publication: United States